Zouboulis, Christos C, Martin M Okun, Robert Gniadecki, Peter A Foley, Charles Lynde, Jamie Weisman, Piyalal Karunaratne, and David A Williams. 2017. “Adalimumab Efficacy in Hidradenitis Suppurativa Patients Is Sustained at Least Three Years With Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)”. SKIN The Journal of Cutaneous Medicine 1 (3.1):s128. https://doi.org/10.25251/skin.1.supp.127.